The Niche - Page 474 of 479 - Knoepfler lab stem cell blog

Stem Cells and Cars

November 29, 2010 Paul Knoepfler 0

It happens several times a month these days. Some new, interesting paper comes out on IPS cells or on transdifferentiation. Immediately, opponents of ES cell research criminally twist the findings in the new paper and produce ‘news’ headlines that pop […]

From Point A to Point Z: thinking outside the box about stem cells

November 29, 2010 Paul Knoepfler 0

What is the best way to get new stem cell-based therapies to the millions of patients who need help? I would argue that this is the key question in the field of stem cell biology and regenerative medicine. Sometimes I […]

Reality check: challenges to getting stem cell treatments to the clinic

November 23, 2010 Paul Knoepfler 0

It has been a rollercoaster few months between the anti-hESC court cases as well as Geron and ACT receiving the OK from the FDA to proceed with initial clinical trials of stem cell-based therapies. It’s OK to be excited about […]

Great news: FDA gives ACT the green light bringing hope to millions of people with blindness

November 22, 2010 Paul Knoepfler 0

The FDA has given Advanced Cell Technology (ACT) the go ahead to begin their clinical trial using retinal progenitor cells derived from hESC by clearing the company’s IND application. The trial will be a combined Phase I/II to treat Stargardt’s […]

NY Times goes tabloid: hit piece on stem cell research and researchers

November 9, 2010 Paul Knoepfler 0

The Science section of the NY times is one of my favorite reads, but today they published a piece that is just terrible. Nicholas Wade, who frequently writes good stuff about science in The NY Times, has an article on […]

The mission of the Knoepfler Lab Blog here at UC Davis School of Medicine is to build stem cell bridges to new treatments and cures through education, outreach, and science.

I encourage readers of this blog to make comments.

There are some rules and key considerations for ipscell.com governing the comments to keep in mind.

Comments will be moderated by a really busy human being so they may not appear right away, particularly if they are very long and/or contain allegations against people or companies, or express inflammatory opinions in which case they may take up to a day or even longer to appear or may never appear.
Comments cannot include personal attacks.
Commenters should avoid being libelous to a person or corporation.
Commenters must use a valid email address.
Commenters generally cannot promote a specific unproven stem cell clinic or physician even by implication.
Commenters are solely responsible for the content of their comments.
I generally do not post comments written by parties referring to other parties who are both involved in an ongoing or pending legal dispute with each other such as litigation. Exceptions to this may be allowed for comments on a blog post that has a topic focused specifically on said legal disputes.
Commenters cannot give medical advice.
Consumers posting comments regarding their opinions of medical treatment they received are solely responsible for that content and readers should understand that such comments reflect opinions, not facts.
Commenters who violate this policy with their submitted comments may temporarily or permanently lose the right to make comments.

By submitting your comment for potential posting on this blog you agree that the comment may be either edited or not posted at all at the blog's discretion if there is concern about non-compliance with this comment policy.

Disclosures

The views expressed on this blog in posts are my own and do not reflect the views of my employer, UC Davis.

I have no financial interests in any stem cell companies or patents in that area.

No material on this website should be considered medical advice and all medical decisions should be discussed with your personal physician first.